Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Debiopharm International SA
Debiopharm International SA
University of Maryland, Baltimore
Boehringer Ingelheim
AstraZeneca
Sichuan University
Bristol-Myers Squibb
Celgene
University of Nebraska
Hoffmann-La Roche
EMD Serono
AbbVie
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
University of California, Davis
University of Pittsburgh
Northwestern University
GlaxoSmithKline